Trial Profile
A Phase IB Study in Patients With Metastatic Colorectal Cancer to Evaluate Pharmacodynamic Effects of Erlotinib and Safety and Efficacy of Erlotinib in Combination With Modified FOLFOX6 (mFOLFOX6) and Bevacizumab.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2012
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary) ; Bevacizumab; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Adverse reactions
- 12 Aug 2011 Planned end date changed from 1 Dec 2011 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 01 Feb 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 01 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.